{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:43:33Z","timestamp":1790455413817,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Methicillin-resistant\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      (MRSA) is a major public health concern, particularly in resource-limited settings such as Africa. This meta-analysis aimed to determine the proportion of MRSA among\n                      <jats:italic>S. aureus<\/jats:italic>\n                      isolates from patients with confirmed infections and to assess associated antibiotic resistance profiles across the continent.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A comprehensive literature search was conducted in African Journals Online, African Index Medicus, PubMed, Scopus, Google Scholar, and Web of Science for studies published between January 1, 2013, and June 5, 2024. Primary studies were included if they reported MRSA proportion or resistance profiles in Africa, employed reliable detection techniques, and analyzed clinical specimens from infected patients. Statistical analyses were performed using the meta package in R software, applying a random-effects model. A\n                      <jats:italic>p<\/jats:italic>\n                      -value of &lt;\u20090.05 was considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This meta-analysis included 191 studies, encompassing 40,979\n                      <jats:italic>S. aureus<\/jats:italic>\n                      isolates. Nigeria contributed the highest number of studies (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200929), followed by Egypt (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200926). The vast majority of studies (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009186) were based on hospital settings. The pooled proportion of MRSA in Africa was 42.2% (95% CI 38.7\u201345.6). By detection method, proportion was 41.4% for\n                      <jats:italic>mecA<\/jats:italic>\n                      , 42.8% for the cefoxitin disc method, and 39.1% for the oxacillin disc method, with no significant differences observed (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.8). Regionally, Northern Africa had a significantly higher proportion of 56.2% (95% CI 49.3\u201362.9) compared with 36.7% (95% CI 33.2\u201340.4) in Sub-Saharan Africa (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). At the country level, Eritrea reported the highest proportion (71.8%), followed by Egypt (61.8%), while the lowest rates were observed in Malawi (7.0%) and Gabon (8.2%). Regarding MRSA resistance profiles, linezolid (3.4%) and vancomycin (4.7%) showed the lowest resistance rates, whereas higher rates were noted for fusidic acid (11.6%), rifampin (28.4%), clindamycin (40.4%), trimethoprim\u2013sulfamethoxazole (54.5%), and tetracycline (60.2%). Limited data were available for telavancin, dalbavancin, oritavancin, tedizolid, ceftaroline, mupirocin, and daptomycin.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The proportion of MRSA in Africa remains high at 42.2%, with marked regional disparities. Although resistance rates for linezolid and vancomycin are relatively low, they surpass global averages, raising concerns about emerging resistance. Alarmingly high resistance rates to several other antibiotics further underscore the urgent need for targeted interventions and continuous surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-025-01687-3","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:56:16Z","timestamp":1768992976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Proportion and antibiogram of methicillin-resistant Staphylococcus aureus (MRSA) in Africa: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Ahmed","family":"Azzam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamad","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelmarouf","family":"Mohieldein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas Mohamed","family":"Lotfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend H. A. M.","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma E.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Marei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouran","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Abdulnaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gellan Alaa Mohamed","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ahmed","family":"Reda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Nazih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitham","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Basil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Rady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"1687_CR1","unstructured":"World AMR. Aug Awareness Week: preventing antimicrobial resistance together. https:\/\/www.who.int\/news\/item\/17-11-2023-world-amr-awareness-week--preventing-antimicrobial-resistance-together. Accessed 11 2025."},{"key":"1687_CR2","unstructured":"Center for Disease Control (CDC). 2019 Antibiotic Resistance Threats Report | Antimicrobial Resistance | CDC. 2019. https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/index.html. Accessed 14 Dec 2024."},{"key":"1687_CR3","unstructured":"World Health Organization (WHO) bacterial priority pathogens list. 2024;:72. https:\/\/www.who.int\/publications\/i\/item\/9789240093461. Accessed 14 Dec 2024."},{"key":"1687_CR4","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1038\/s41598-020-60825-6","volume":"10","author":"X Zhen","year":"2020","unstructured":"Zhen X, Lundborg CS, Zhang M, Sun X, Li Y, Hu X, et al. Clinical and economic impact of methicillin-resistant Staphylococcus aureus: a multicentre study in China. Sci Rep. 2020;10:3900.","journal-title":"Sci Rep"},{"key":"1687_CR5","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1001\/archinte.162.19.2229","volume":"162","author":"SI Blot","year":"2002","unstructured":"Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med. 2002;162:2229\u201335.","journal-title":"Arch Intern Med"},{"key":"1687_CR6","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1017\/ice.2015.22","volume":"36","author":"RE Nelson","year":"2015","unstructured":"Nelson RE, Jones M, Liu CF, Samore MH, Evans ME, Graves N, et al. The impact of healthcare-associated methicillin-resistant Staphylococcus aureus infections on Post-Discharge healthcare costs and utilization. Infect Control Hosp Epidemiol. 2015;36:534\u201342.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1687_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1086\/345476","volume":"36","author":"SE Cosgrove","year":"2003","unstructured":"Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53\u20139.","journal-title":"Clin Infect Dis"},{"key":"1687_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1128\/jb.158.2.513-516.1984","volume":"158","author":"BJ Hartman","year":"1984","unstructured":"Hartman BJ, Tomasz A. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol. 1984;158:513.","journal-title":"J Bacteriol"},{"key":"1687_CR9","unstructured":"Methicillin-resistant Staphylococcus aureus | A.R. & Patient Safety Portal. https:\/\/arpsp.cdc.gov\/profile\/antibiotic-resistance\/methicillin-resistant-staphylococcus-aureus. Accessed 17 Dec 2024."},{"key":"1687_CR10","first-page":"363","volume":"137","author":"S Joshi","year":"2013","unstructured":"Joshi S, Ray P, Manchanda V, Bajaj J, Chitnis DS, Gautam V, et al. Methicillin resistant Staphylococcus aureus (MRSA) in india: prevalence & susceptibility pattern. Indian J Med Res. 2013;137:363.","journal-title":"Indian J Med Res"},{"key":"1687_CR11","unstructured":"National Antimicrobial Surveillance Network (NARS-Net) Ministry of Health and Family Welfare Government of India. 2023;:1\u201346. https:\/\/ncdc.mohfw.gov.in\/wp-content\/uploads\/2024\/03\/87909365291642417515.pdf. Accessed 17 Dec 2024."},{"key":"1687_CR12","unstructured":"Antimicrobial resistance surveillance in. Europe 2023\u2009\u2013\u20092021 data. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-surveillance-europe-2023-2021-data. Accessed 17 Dec 2024."},{"key":"1687_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2147\/DMSO.S446911","volume":"17","author":"S Zhou","year":"2024","unstructured":"Zhou S, Hu X, Wang Y, Fei W, Sheng Y, Que H. The global prevalence of Methicillin-Resistant Staphylococcus aureus in patients with diabetic foot ulcers: a systematic review and meta-analysis. Diabetes Metab Syndr Obes. 2024;17:563.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1687_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-023-01210-6","volume":"12","author":"AH Hasanpour","year":"2023","unstructured":"Hasanpour AH, Sepidarkish M, Mollalo A, Ardekani A, Almukhtar M, Mechaal A, et al. The global prevalence of methicillin-resistant Staphylococcus aureus colonization in residents of elderly care centers: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2023;12:1\u201311.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1687_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jgar.2020.03.009","volume":"22","author":"MR Akpan","year":"2020","unstructured":"Akpan MR, Isemin NU, Udoh AE, Ashiru-Oredope D. Implementation of antimicrobial stewardship programmes in African countries: a systematic literature review. J Glob Antimicrob Resist. 2020;22:317\u201324.","journal-title":"J Glob Antimicrob Resist"},{"key":"1687_CR16","unstructured":"Antimicrobial Resistance Surveillance Guidance for the African Region \u2013 Africa CDC. https:\/\/africacdc.org\/download\/antimicrobial-resistance-surveillance-guidance-for-the-african-region\/. Accessed 17 Dec 2024."},{"key":"1687_CR17","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1007\/s40615-023-01610-9","volume":"11","author":"U Abubakar","year":"2024","unstructured":"Abubakar U, Salman M. Antibiotic use among hospitalized patients in africa: a systematic review of point prevalence studies. J Racial Ethn Heal Disparities. 2024;11:1308\u201329.","journal-title":"J Racial Ethn Heal Disparities"},{"key":"1687_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-024-01462-w","volume":"13","author":"MY Gobezie","year":"2024","unstructured":"Gobezie MY, Tesfaye NA, Faris AG, Hassen M. Surveillance of antimicrobial utilization in africa: a systematic review and meta-analysis of prescription rates, indications, and quality of use from point prevalence surveys. Antimicrob Resist Infect Control. 2024;13:1\u201313.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1687_CR19","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/antibiotics12030612","volume":"12","author":"MA Hussain","year":"2023","unstructured":"Hussain MA, Mohamed AO, Abdelkarim OA, Yousef BA, Babikir AA, Mirghani MM, et al. Prevalence and predictors of antibiotic Self-Medication in sudan: a descriptive cross-sectional study. Antibiotics. 2023;12:612.","journal-title":"Antibiotics"},{"key":"1687_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-019-7020-x","volume":"19","author":"Y Ateshim","year":"2019","unstructured":"Ateshim Y, Bereket B, Major F, Emun Y, Woldai B, Pasha I, et al. Prevalence of self-medication with antibiotics and associated factors in the community of Asmara, eritrea: A descriptive cross sectional survey. BMC Public Health. 2019;19:1\u20137.","journal-title":"BMC Public Health"},{"key":"1687_CR21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1080\/14787210.2021.1857731","volume":"19","author":"J Chen","year":"2021","unstructured":"Chen J, Sidibi AM, Shen X, Dao K, Maiga A, Xie Y, et al. Lack of antibiotic knowledge and misuse of antibiotics by medical students in mali: a cross-sectional study. Expert Rev Anti Infect Ther. 2021;19:797\u2013804.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1687_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3889\/oamjms.2020.3323","volume":"8 E","author":"NMK Elden","year":"2020","unstructured":"Elden NMK, Nasser HA, Alli A, Mahmoud N, Shawky MA, Ibrahim AAEA, et al. Risk factors of antibiotics Self-medication practices among university students in Cairo, Egypt. Open Access Maced J Med Sci. 2020;8 E:7\u201312.","journal-title":"Open Access Maced J Med Sci"},{"key":"1687_CR23","unstructured":"FDA Approval Of HIV Medicines."},{"key":"1687_CR24","first-page":"1363","volume":"27","author":"A Khawaja","year":"2020","unstructured":"Khawaja A, Javed I, Mushtaq S, Anwar S, Arshad F, Raja NA. Detection of MecA gene by latex agglutination and its molecular analysis by PCR in methicillin resistant Staphylococcus aureus. Prof Med J. 2020;27:1363\u201370.","journal-title":"Prof Med J"},{"key":"1687_CR25","first-page":"281","volume":"27","author":"OMA Ibrahim","year":"2017","unstructured":"Ibrahim OMA, Bilal NE, Osman OF, Magzoub MA. Assessment of methicillin resistant Staphylococcus aureus detection methods: analytical comparative study. Pan Afr Med J. 2017;27:281.","journal-title":"Pan Afr Med J"},{"key":"1687_CR26","first-page":"341","volume":"6","author":"MR Pourmand","year":"2014","unstructured":"Pourmand MR, Hassanzadeh S, Mashhadi R, Askari E. Comparison of four diagnostic methods for detection of methicillin resistant Staphylococcus aureus. Iran J Microbiol. 2014;6:341.","journal-title":"Iran J Microbiol"},{"key":"1687_CR27","unstructured":"JBI Critical Appraisal Tools | JBI. https:\/\/jbi.global\/critical-appraisal-tools. Accessed 19 Dec 2024."},{"key":"1687_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-021-00459-2","volume":"20","author":"WM Abdelraheem","year":"2021","unstructured":"Abdelraheem WM, Khairy RMM, Zaki AI, Zaki SH. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates. Ann Clin Microbiol Antimicrob. 2021;20:1\u201311.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"1687_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.14202\/IJOH.2017.46-49","volume":"3","author":"AB Karikari","year":"2017","unstructured":"Karikari AB, Frimpong E, Owusu-Ofori A. Methicillin-resistant Staphylococcus aureus among patients in a teaching hospital in Ghana. Int J One Heal. 2017;3:46\u20139.","journal-title":"Int J One Heal"},{"key":"1687_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4314\/ajcem.v16i3.7","volume":"16","author":"O Obasuyi","year":"2015","unstructured":"Obasuyi O, Akerele J. High incidence of multidrug-resistant strains of methicill inresistant Staphylococcus aureus isolated from clinical samples in Benin-City, Nigeria. Afr J Clin Exp Microbiol. 2015;16:124\u20137.","journal-title":"Afr J Clin Exp Microbiol"},{"key":"1687_CR31","first-page":"7","volume":"42","author":"E Yusuf","year":"2015","unstructured":"Yusuf E, Airauhi L. Prevalence and pattern of methicillin resistant Staphylococcus aureus in a tertiary healthcare facility in Nigeria. Med J Zambia. 2015;42:7\u201311.","journal-title":"Med J Zambia"},{"key":"1687_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.54117\/jcbr.v2i2.13","volume":"2","author":"EL Okoye","year":"2022","unstructured":"Okoye EL, Omeje MJ, Ugwuoji ET. Detection and prevalence of methicillin- and vancomycin-resistant Staphylococcus aureus among clinical isolates in ESUTH, Enugu state. J Curr Biomed Res. 2022;2:170\u201386.","journal-title":"J Curr Biomed Res"},{"key":"1687_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4236\/ojmm.2016.61003","volume":"6","author":"C Akoru","year":"2016","unstructured":"Akoru C, Kuremu RT, Ndege SK, Obala A, Smith JW, Bartlett M, et al. Prevalence and Anti-Microbial susceptibility of methicillin resistant Staphylococcus aureus at Moi teaching and referral hospital Eldoret. Open J Med Microbiol. 2016;6:9\u201316.","journal-title":"Open J Med Microbiol"},{"key":"1687_CR34","doi-asserted-by":"publisher","first-page":"860467","DOI":"10.1155\/2013\/860467","volume":"2013","author":"CE Udobi","year":"2013","unstructured":"Udobi CE, Obajuluwa AF, Onaolapo JA. Prevalence and antibiotic resistance pattern of Methicillin-Resistant Staphylococcus aureus from an orthopaedic hospital in Nigeria. Biomed Res Int. 2013;2013:860467.","journal-title":"Biomed Res Int"},{"key":"1687_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.47430\/ujmr.2271.007","volume":"7","author":"KC Mofolorunsho","year":"2022","unstructured":"Mofolorunsho KC, Emmanuel MT, Omatola CA, Aminu RF, Ocheni HO. Prevalence and antibiotic resistance profiles of Methicillin-Resistant Staphylococcus aureus isolated from clinical specimens in Anyigba, Nigeria. UMYU J Microbiol Res. 2022;7:38\u201346.","journal-title":"UMYU J Microbiol Res"},{"key":"1687_CR36","first-page":"43","volume":"16","author":"ESH Ibrahim","year":"2020","unstructured":"Ibrahim ESH, El-Baghdady K, Abd El-All SM, Warda MAA, Prince AM, Ibrahim M. Prevalence of multidrug resistance in the Egyptian methicillin-resistant Staphylococcus aureus isolates. Afr J Biol Sci. 2020;16:43\u201352.","journal-title":"Afr J Biol Sci"},{"key":"1687_CR37","first-page":"36","volume":"3","author":"FI Sonbol","year":"2022","unstructured":"Sonbol FI, Abdelaziz AA, El-banna TE-S, Farag O. Detection and characterization of Staphylococcus aureus and Methicillin-resistant S. aureus (MRSA) in ear infections in Tanta, Egypt. J Adv Med Pharm Res. 2022;3:36\u201344.","journal-title":"J Adv Med Pharm Res"},{"key":"1687_CR38","doi-asserted-by":"publisher","first-page":"786378","DOI":"10.3389\/fitd.2021.786378","volume":"2","author":"S Wireko","year":"2021","unstructured":"Wireko S, Asiedu SO, Kini P, Aglomasa BC, Amewu EKA, Asiedu E, et al. Prevalence of Methicillin-Resistant Staphylococcus species among filarial lymphedema patients in Ahanta West district of Ghana. Front Trop Dis. 2021;2:786378.","journal-title":"Front Trop Dis"},{"key":"1687_CR39","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3855\/jidc.17920","volume":"17","author":"R Aniba","year":"2023","unstructured":"Aniba R, Barguigua A, Dihmane A, Momen G, Nayme K, Timinouni M. Prevalence and antibacterial resistance patterns of uropathogenic Staphylococci in Casablanca, Morocco. J Infect Dev Ctries. 2023;17:1436\u201345.","journal-title":"J Infect Dev Ctries"},{"key":"1687_CR40","first-page":"2665","volume":"22","author":"A Rahmani","year":"2021","unstructured":"Rahmani A, Meradi L, Malawi K, Khanfouf F. Phenotypic characterization of antimicrobial drug resistance of Staphylococcus aureus and S. epidermidis strains isolated from various community infections in Oum El Bouaghi city, Algeria. Biodiversitas J Biol Divers. 2021;22:2665\u201371.","journal-title":"Biodiversitas J Biol Divers"},{"key":"1687_CR41","first-page":"780","volume":"7","author":"T Rahima","year":"2015","unstructured":"Rahima T, Nafissa B, Abdelghani D. Prevalence of methicillin-resistant Staphylococcus aureus and\/or intermediate susceptibility to Vancomycin isolated from private laboratories in Annaba. J Chem Pharm Res. 2015;7:780\u20136.","journal-title":"J Chem Pharm Res"},{"key":"1687_CR42","doi-asserted-by":"crossref","unstructured":"Lai PS, Bebell LM, Meney C, Valeri L, White MC. Epidemiology of antibiotic-resistant wound infections from six countries in Africa. BMJ Glob Heal. 2018;2 Suppl 4:475.","DOI":"10.1136\/bmjgh-2017-000475"},{"key":"1687_CR43","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/jac\/dkad078","volume":"78","author":"GB Carey","year":"2023","unstructured":"Carey GB, Holleck JL, Alshaeba SE, Jayakrishnan R, Gordon KS, Grimshaw AA, et al. Estimated mortality with early empirical antibiotic coverage of methicillin-resistant Staphylococcus aureus in hospitalized patients with bacterial infections: a systematic review and meta-analysis. J Antimicrob Chemother. 2023;78:1150\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"1687_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jac\/dkac342","volume":"78","author":"OJ Okolie","year":"2022","unstructured":"Okolie OJ, Igwe U, Ismail SU, Ighodalo UL, Adukwu EC. Systematic review of surveillance systems for AMR in Africa. J Antimicrob Chemother. 2022;78:31.","journal-title":"J Antimicrob Chemother"},{"key":"1687_CR45","doi-asserted-by":"publisher","unstructured":"Guo Y, Ding L, Yang Y, Han R, Yin D, Wu S et al. Multicenter Antimicrobial Resistance Surveillance of Clinical Isolates from Major Hospitals\u2014China, 2022. China CDC Weekly. 2023;5:1155\u201360. https:\/\/weekly.chinacdc.cn\/en\/article\/doi\/https:\/\/doi.org\/10.46234\/ccdcw2023.217. Accessed 17 Dec 2024.","DOI":"10.46234\/ccdcw2023.217"},{"key":"1687_CR46","unstructured":"Vancomycin-resistant, MRSA | A.R. & Patient Safety Portal. https:\/\/arpsp.cdc.gov\/profile\/antibiotic-resistance\/vancomycin-resistant-mrsa. Accessed 17 Dec 2024."},{"key":"1687_CR47","unstructured":"Linezolid-resistant, MRSA | A.R. & Patient Safety Portal. https:\/\/arpsp.cdc.gov\/profile\/antibiotic-resistance\/linezolid-resistant-mrsa. Accessed 17 Dec 2024."},{"key":"1687_CR48","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1093\/jac\/dkx251","volume":"72","author":"MA Pfaller","year":"2017","unstructured":"Pfaller MA, Mendes RE, Streit JM, Hogan PA, Flamm RK. ZAAPS program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countries. J Antimicrob Chemother. 2017;72:3093\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"1687_CR49","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1128\/AAC.02803-15","volume":"60","author":"RK Flamm","year":"2016","unstructured":"Flamm RK, Mendes RE, Hogan PA, Streit JM, Ross JE, Jonesa RN. Linezolid surveillance results for the united States (LEADER surveillance program 2014). Antimicrob Agents Chemother. 2016;60:2273.","journal-title":"Antimicrob Agents Chemother"},{"key":"1687_CR50","doi-asserted-by":"publisher","first-page":"664199","DOI":"10.3389\/fmicb.2021.664199","volume":"12","author":"R Markwart","year":"2021","unstructured":"Markwart R, Willrich N, Eckmanns T, Werner G, Ayobami O. Low proportion of linezolid and daptomycin resistance among bloodborne vancomycin-resistant enterococcus faecium and methicillin-resistant Staphylococcus aureus infections in Europe. Front Microbiol. 2021;12:664199.","journal-title":"Front Microbiol"},{"key":"1687_CR51","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18\u201355.","journal-title":"Clin Infect Dis"},{"key":"1687_CR52","doi-asserted-by":"publisher","first-page":"s418","DOI":"10.1017\/ice.2020.1074","volume":"41","author":"DC Ham","year":"2020","unstructured":"Ham DC, Fike L, Fulton T, Dotson N, Perlmutter R, Kalp E, et al. Trimethoprim-sulfamethoxazole resistance patterns among methicillin-resistant Staphylococcus aureus, 2012\u20132018. Infect Control Hosp Epidemiol. 2020;41:s418\u2013418.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1687_CR53","doi-asserted-by":"crossref","unstructured":"Gurung RR, Maharjan P, Chhetri GG. Antibiotic resistance pattern of Staphylococcus aureus with reference to MRSA isolates from pediatric patients. Futur Sci OA. 2020;6.","DOI":"10.2144\/fsoa-2019-0122"},{"key":"1687_CR54","first-page":"1979","volume":"7","author":"A Kali","year":"2013","unstructured":"Kali A, Stephen S, Umadevi S, Kumar S, Joseph NM, Srirangaraj S. Changing trends in resistance pattern of methicillin resistant Staphylococcus aureus. J Clin Diagn Res. 2013;7:1979.","journal-title":"J Clin Diagn Res"},{"key":"1687_CR55","first-page":"e72628","volume":"16","author":"PP Patil","year":"2024","unstructured":"Patil PP, Patil HV, Patil S. Evaluation of antibiotic sensitivity in Methicillin-Resistant Staphylococcus aureus isolates from clinical specimens in a tertiary care hospital. Cureus. 2024;16:e72628.","journal-title":"Cureus"},{"key":"1687_CR56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4103\/JLP.JLP_8_17","volume":"9","author":"S Singh","year":"2017","unstructured":"Singh S, Malhotra R, Grover P, Bansal R, Galhotra S, Kaur R, et al. Antimicrobial resistance profile of Methicillin-resistant Staphylococcus aureus colonizing the anterior Nares of health-care workers and outpatients attending the remotely located tertiary care hospital of North India. J Lab Physicians. 2017;9:317\u201321.","journal-title":"J Lab Physicians"},{"key":"1687_CR57","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3855\/jidc.86","volume":"3","author":"HK Tiwari","year":"2009","unstructured":"Tiwari HK, Das AK, Sapkota D, Sivarajan K, Pahwa VK. Methicillin resistant  Staphylococcus aureuss: prevalence and antibiogram in A tertiary care hospital in Western Nepal. J Infect Dev Ctries. 2009;3:681\u20134.","journal-title":"J Infect Dev Ctries"},{"key":"1687_CR58","first-page":"163","volume":"6","author":"S Dibah","year":"2014","unstructured":"Dibah S, Arzanlou M, Jannati E, Shapouri R. Prevalence and antimicrobial resistance pattern of methicillin resistant  Staphylococcus aureus (MRSA) strains isolated from clinical specimens in Ardabil, Iran. Iran J Microbiol. 2014;6:163.","journal-title":"Iran J Microbiol"},{"key":"1687_CR59","doi-asserted-by":"crossref","unstructured":"Ong MH-L, Ho W-Y, Ng W-W, Chew C-H, Ong MH-L, Ho W-Y et al. High Prevalence of tetM as Compared to tetk amongst methicillin-resistant Staphylococcus aureus (MRSA) Isolates from Hospitals in Perak, Malaysia. Jundishapur J Microbiol. 2017;10.","DOI":"10.5812\/jjm.13935"},{"key":"1687_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-025-10819-4","volume":"25","author":"A Azzam","year":"2025","unstructured":"Azzam A, Khaled H, Fayed HM, Mansour Y, Eldalil M, Elshennawy E, et al. Prevalence, antibiogram, and risk factors of methicillin-resistant Staphylococcus aureus (MRSA) asymptomatic carriage in africa: a systematic review and meta-analysis. BMC Infect Dis. 2025;25:1\u201313.","journal-title":"BMC Infect Dis"},{"key":"1687_CR61","doi-asserted-by":"publisher","first-page":"860436","DOI":"10.3389\/fmicb.2022.860436","volume":"13","author":"OU Lawal","year":"2022","unstructured":"Lawal OU, Ayobami O, Abouelfetouh A, Mourabit N, Kaba M, Egyir B, et al. A 6-Year update on the diversity of methicillin-resistant Staphylococcus aureus clones in africa: a systematic review. Front Microbiol. 2022;13:860436.","journal-title":"Front Microbiol"},{"key":"1687_CR62","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/jrsm.1547","volume":"13","author":"CB Migliavaca","year":"2022","unstructured":"Migliavaca CB, Stein C, Colpani V, Barker TH, Ziegelmann PK, Munn Z, et al. Meta-analysis of prevalence: I2 statistic and how to deal with heterogeneity. Res Synth Methods. 2022;13:363\u20137.","journal-title":"Res Synth Methods"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-025-01687-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01687-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01687-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:06:09Z","timestamp":1769605569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13756-025-01687-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1687"],"URL":"https:\/\/doi.org\/10.1186\/s13756-025-01687-3","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"25 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}